Navigation Links
Senator Dean Barkley Pledges Action on HIV/AIDS Epidemic
Date:10/28/2008

ST. PAUL, Minn., Oct. 28 /PRNewswire-USNewswire/ -- Dean Barkley, candidate for US Senate from Minnesota, has signed a pledge to support a comprehensive strategy to fight HIV/AIDS in the US and around the world.

"We hope that Al Franken, Norm Coleman and other candidates from Minnesota will also agree to sign the pledge," said Dr. Paul Zeitz, Executive Director of the Global AIDS Alliance Fund. "The pledge helps voters see who is prepared to take a bold stand on this issue."

Barkley joins fifteen other Congressional candidates who have signed the pledge. The full list of signers and the text of the pledge can be found at http://www.globalaidsalliancefund.org.

4,845 people in Minnesota are HIV positive, and there are about 200 new infections in MN each year, according to the US government.

The pledge includes a funding commitment that would mean continued research dollars for Minnesota's world class health research centers.

"HIV/AIDS is a major issue in Minnesota, and we congratulate Dean Barkley for pledging the kind of leadership we need in the fight against AIDS," said Zeitz.

HIV/AIDS prevention efforts are paying off, but, at a global level, the disease still infects 7,500 people each day. In 2007 the disease killed 2 million people.

The pledge, sponsored by AIDS Action Council and the Global AIDS Alliance Fund, commits candidates to a focus on the prevention and treatment needs of African Americans, other communities of color, gay men, and other groups at elevated risk.

Approximately 56,000 people are infected with HIV each year in the United States.

The pledge also commits candidates to backing a thorough reform of foreign aid, to ensure that US aid to alleviate poverty is well spent and to streamline the aid bureaucracy.

Fighting global poverty has strong bipartisan support, even with the financial crisis looming.

Last week, Secretary of State Condoleezza Rice stated: "Of course, some will ask the inevitable question in these troubled times -- how can we afford it? I would ask instead -- how can we not afford it? How can we afford not to support weak, poor, and poorly governed states that as we have seen, can destabilize the world in the 21st century?"

Both Senators McCain and Obama have backed continued aid, though progress on AIDS would be stalled by the spending freeze McCain has proposed.

CONTACT: David Bryden, +1-202-789-0432 x 211, +1-202-549-3664


'/>"/>
SOURCE Global AIDS Alliance Fund
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
2. AIDS Action Council Commends Senator Edwards for Endorsing a National HIV/AIDS Strategy
3. Congressional Support Grows for FDA Regulation of Tobacco: Bill Now Sponsored by 55 Senators, 200 Representatives
4. NAMI Statement on U.S. Senator Pete Domenici Retirement
5. Governor Ruth Ann Minner, U.S. Senator Tom Carper, U.S. Representative Mike Castle and Lt. Governor John Carney Join 125 Delaware Community Leaders Endorsing the Campaign to Make Delawares Kids the Healthiest in the Nation
6. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
7. Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for Americas Returning Wounded Warriors Report Implementation
8. National Patient Advocate Foundation Hails Senator Rockefeller for Introducing Bill Protecting Patient Access to Health Coverage
9. Committee to Reduce Infection Deaths Applauds Senator Durbins Hospital Infection Legislation, but Suggests Some Crucial Additions in Order to Combat Soaring MRSA Rates
10. CHPA Commends Senator Biden on Legislation Aimed at Curbing Medicine-Abuse Trend
11. Lung Cancer Alliance Hails Massachusetts Senator for Taking Lead on Lung Cancer Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... Aliso Viejo, California (PRWEB) , ... December 04, ... ... self-animating lower third presets that have new attractive animation styles with unique displacement ... Pro3rd Displace features 30 pre-animated lower third designs. Choose from a variety of ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: